Lili Feng, Rongrong Du, Baitong Chang, et al. Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. [J]. Genes & Diseases 10(5).(2023)
DOI:
Lili Feng, Rongrong Du, Baitong Chang, et al. Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. [J]. Genes & Diseases 10(5).(2023) DOI: 10.1016/j.gendis.2022.08.018.
Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities
摘要
Abstract
N
6
-methyladenosine (m
6
A) RNA modification is widely perceived as the most abundant and common modification in transcripts. This modification is dynamically regulated by specific m
6
A “writers”
“erasers” and “readers” and is reportedly involved in the occurrence and development of many diseases. Since m
6
A RNA modification was discovered in the 1970s
with the progress of relevant research technologies
an increasing number of functions of m
6
A have been reported
and a preliminary understanding of m
6
A has been obtained. In this review
we summarize the mechanisms through which m
6
A RNA modification is regulated from the perspectives of expression
posttranslational modification and protein interaction. In addition
we also summarize how external and internal environmental factors affect m
6
A RNA modification and its functions in tumors. The mechanisms through which m
6
A methylases
m
6
A demethylases and m
6
A-binding proteins are regulated are complicated and have not been fully elucidated. Therefore
we hope to promote further research in this field by summarizing these mechanisms and look forward to the future application of m
Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer
IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer
Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?
Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management
Related Author
David Sánchez-Marín
Macrina Beatriz Silva-Cázares
Fany Iris Porras-Reyes
Rebeca García-Román
Alma D. Campos-Parra
Meiqi Duan
Haiyang Liu
Shasha Xu
Related Institution
Unidad Académica Multidisciplinaria Región Altiplano, Universidad Autónoma de San Luis Potosí (UASLP), Carretera a Cedral Km 5+600, Ejido San José de la Trojes, Matehuala, San Luis Potosí, C.P. 78760, México
Servicio de Anatomía Patológica, Instituto Nacional de Cancerología (INCan), Niño Jesús, Tlalpan, Ciudad de México, C.P. 14080, México
Instituto de Salud Pública, Universidad Veracruzana (UV), Av. Dr Luis, Dr. Castelazo Ayala s/n, Col. Industrial Ánimas, Xalapa, Veracruz, C.P. 91190, México
Posgrado en Ciencias Biológicas, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, C.P. 04360, México
Department of Gastroendoscopy, The Fourth Affiliated Hospital of China Medical University